We are live on ! Find out more
COLL icon

Collegium Pharmaceutical
COLL

174 hedge funds and large institutions have $865M invested in Collegium Pharmaceutical in 2023 Q3 according to their latest regulatory filings, with 17 funds opening new positions, 74 increasing their positions, 59 reducing their positions, and 21 closing their positions.

New
Increased
Maintained
Reduced
Closed

25% more repeat investments, than reductions

Existing positions increased: 74 | Existing positions reduced: 59

3% more capital invested

Capital invested by funds: $843M → $865M (+$21.8M)

0% more funds holding in top 10

Funds holding in top 10: 3 → 3 (0)

2.15% less ownership

Funds ownership: 113.43% → 111.28% (-2.2%)

2% less funds holding

Funds holding: 178 → 174 (-4)

19% less first-time investments, than exits

New positions opened: 17 | Existing positions closed: 21

82% less call options, than puts

Call options by funds: $239K | Put options by funds: $1.3M

Holders
174
Holders Change
-4
Holders Change %
-2.25%
% of All Funds
2.76%
Holding in Top 10
3
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.05%
New
17
Increased
74
Reduced
59
Closed
21
Calls
$239K
Puts
$1.3M
Net Calls
-$1.06M
Net Calls Change
+$113K

Top Buyers

1
Pacer Advisors
Pacer Advisors
Pennsylvania
+$11.7M
2
Assenagon Asset Management
Assenagon Asset Management
Luxembourg
+$6.22M
3
BlackRock
BlackRock
New York
+$3.71M
4
Millennium Management
Millennium Management
New York
+$3.24M
5
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT)
United Kingdom
+$2.54M

Top Sellers

1
MIIM
Mesirow Institutional Investment Management
Illinois
-$9.37M
2
RCMNY
Rubric Capital Management (New York)
New York
-$5.7M
3
Janus Henderson Group
Janus Henderson Group
United Kingdom
-$4.47M
4
LSV Asset Management
LSV Asset Management
Illinois
-$4.45M
5
TA
Tamarack Advisers
California
-$4.33M
Name Holding Trade Value Shares
Change 		Change in
Stake
BGIM
26
Brandywine Global Investment Management
Pennsylvania
$8.57M -$54.9K -2,405 -0.6%
APM
27
Avidity Partners Management
Texas
$7.83M -$88.9K -3,900 -1%
Two Sigma Investments
28
Two Sigma Investments
New York
$7.8M -$379K -16,616 -5%
Bank of New York Mellon
29
Bank of New York Mellon
New York
$6.96M -$208K -9,136 -3%
Charles Schwab
30
Charles Schwab
California
$6.93M +$335K +14,667 +5%
Two Sigma Advisers
31
Two Sigma Advisers
New York
$6.91M -$13.7K -600 -0.2%
TC
32
Tejara Capital
United Kingdom
$6.48M -$340K -14,886 -5%
Loomis, Sayles & Company
33
Loomis, Sayles & Company
Massachusetts
$6.12M +$1.54M +67,439 +33%
SDIC
34
South Dakota Investment Council
South Dakota
$5.45M -$120K -5,254 -2%
Goldman Sachs
35
Goldman Sachs
New York
$4.67M -$87K -3,815 -2%
TA
36
Tamarack Advisers
California
$4.13M -$4.33M -190,000 -51%
AllianceBernstein
37
AllianceBernstein
Tennessee
$3.31M +$1.24M +54,227 +58%
D.E. Shaw & Co
38
D.E. Shaw & Co
New York
$3.24M +$764K +33,505 +30%
JP Morgan Chase
39
JP Morgan Chase
New York
$3.22M +$796K +34,909 +32%
SEI Investments
40
SEI Investments
Pennsylvania
$3M -$299K -13,108 -9%
TI
41
Trexquant Investment
Connecticut
$2.97M +$745K +32,680 +33%
LPL Financial
42
LPL Financial
California
$2.89M -$290K -12,713 -9%
Qube Research & Technologies (QRT)
43
Qube Research & Technologies (QRT)
United Kingdom
$2.84M +$2.54M +111,394 +713%
MOACM
44
Mutual of America Capital Management
New York
$2.71M -$172K -7,535 -6%
Federated Hermes
45
Federated Hermes
Pennsylvania
$2.7M +$421K +18,464 +18%
Ameriprise
46
Ameriprise
Minnesota
$2.6M -$240K -10,506 -8%
RhumbLine Advisers
47
RhumbLine Advisers
Massachusetts
$2.46M +$22.5K +988 +0.9%
AQR Capital Management
48
AQR Capital Management
Connecticut
$2.33M +$1.26M +55,138 +112%
UIC
49
Uniplan Investment Counsel
Wisconsin
$2.32M +$2.34M +102,616 New
CC
50
Clearline Capital
New York
$2.27M +$200K +8,754 +9%
1
2
3 4 5

COLL Hedge Fund Activity: Q3 2023 in Review

174 of the 6,301 institutional investors tracked by Wall St. Rank reported a position in Collegium Pharmaceutical (COLL) for Q3 2023, worth a combined $865M — up 2.6% from $843M a quarter earlier.

Sellers outnumbered buyers: 21 funds closed out of COLL and 17 opened new positions — a net loss of 4 holders — while 59 trimmed existing stakes and 74 added.

The largest buyer was Pacer Advisors, adding an estimated $11.7M. The largest seller was Mesirow Institutional Investment Management, exiting entirely with an estimated $9.37M sold.

  • 174 institutional investors held Collegium Pharmaceutical (COLL) as of Q3 2023, down from 178 in Q2 2023.
  • Funds reported $865M of Collegium Pharmaceutical stock for Q3 2023, up 2.6% quarter-over-quarter.
  • 17 funds opened new Collegium Pharmaceutical positions in Q3 2023 and 21 closed out, a net change of -4 holders.
  • The largest Collegium Pharmaceutical buyer in Q3 2023 was Pacer Advisors, an estimated $11.7M added.
  • The largest Collegium Pharmaceutical seller in Q3 2023 was Mesirow Institutional Investment Management, an estimated $9.37M sold.

Based on aggregated 13F filings for Q3 2023.